FDA advisory panels votes 16-2 against boosting Pfizer share price

An influential Food and Drug Administration advisory committee on Friday resoundingly rejected a plan to administer booster shots of Pfizer and BioNTech’s Covid-19 vaccine to the general public….

The final tally failed 16-2.

Source: FDA panel rejects plan to administer Pfizer’s Covid booster doses to general public

The panel is still considering an option for those aged 60 or 65 and older.

Update: They approved a booster shot for those age 65+ only. It is amazing how the need is a square wave function at age 64 to 65. Zero need at age 64 and 364 days, and then a need one day later.